Indian Regulatory And Industry Bodies Call For Open Dialog With Policymakers

By Akriti Seth


The Indian pharmaceutical industry’s contribution has become even more prominent in 2020 and 2021, as India has supported the global battle against the COVID-19 pandemic by managing to maintain drug supplies to almost 200 countries even during the darkest days.

IPA's Global Innovation Summit 2021 aligned with the commitment of the government to promote Indian pharmaceuticals as a globally competitive sector by ensuring access, quality and affordability of medicines in domestic and global markets.

This article supplies direct quotes from Indian prime minister Narendra Modi and secretary of India’s Department of Pharmaceuticals S Aparna on how the Summit saw regulatory and industry bodies call for policy intervention to provide support and incentives for innovation and R&D in the Indian pharmaceutical sector.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Med Device Online? Subscribe today.

Subscribe to Med Device Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Med Device Online

West Pharmaceutical Services, Inc.